| 03/04/24 | 07:30:00 | 3 Apr 2024 | | Suspension - MGC Pharmaceuticals Limited |
| 02/04/24 | 15:40:42 | 2 Apr 2024 | | Change of name to Argent BioPharma Limited |
| 28/03/24 | 09:12:48 | 28 Mar 2024 | | PDMR Notification |
| 28/03/24 | 09:07:18 | 28 Mar 2024 | | Refinancing of Convertible Securities Agreement |
| 18/03/24 | 08:23:32 | 18 Mar 2024 | | Results of General Meeting |
| 29/02/24 | 09:36:13 | 29 Feb 2024 | | Half-year Report |
| 19/02/24 | 16:00:01 | 19 Feb 2024 | | Update - Application for Admission to Trading |
| 13/02/24 | 10:00:00 | 13 Feb 2024 | | Dispatch of General Meeting Documents |
| 13/02/24 | 09:01:19 | 13 Feb 2024 | | Application for Admission to Trading |
| 31/01/24 | 07:30:00 | 31 Jan 2024 | | December 2023 Quarter Activity Report |
| 11/01/24 | 09:54:12 | 11 Jan 2024 | | Director/PDMR Shareholding |
| 22/12/23 | 09:09:34 | 22 Dec 2023 | | Company Update & Placing to Raise US$500,000 |
| 19/12/23 | 07:57:31 | 19 Dec 2023 | | ArtemiC™ receives FDA Approval in Saudi Arabia |
| 18/12/23 | 09:06:51 | 18 Dec 2023 | | Non-Deal Roadshow Presentation December 2023 |
| 01/12/23 | 08:09:32 | 1 Dec 2023 | | Corporate Update - Board and UK Adviser Changes |
| 30/11/23 | 09:08:05 | 30 Nov 2023 | | Results of Shareholder’s Annual General Meeting |
| 16/11/23 | 13:51:44 | 16 Nov 2023 | | Holding(s) in Company |
| 13/11/23 | 09:15:27 | 13 Nov 2023 | | Holding(s) in Company |
| 09/11/23 | 10:47:05 | 9 Nov 2023 | | Holding(s) in Company |
| 08/11/23 | 11:52:55 | 8 Nov 2023 | | Holding(s) in Company |
| 08/11/23 | 10:00:00 | 8 Nov 2023 | | Capital Consolidation and US$7.9m Placement |
| 01/11/23 | 11:30:01 | 1 Nov 2023 | | Consolidation and New Fund Raising |
| 01/11/23 | 11:03:49 | 1 Nov 2023 | | MGC Secures US$7.9 Million In Firm Commitments |
| 31/10/23 | 09:32:51 | 31 Oct 2023 | | Dispatch of Annual General Meeting Documents |
| 30/10/23 | 07:16:04 | 30 Oct 2023 | | September 2023 Quarter Activity Report |
| 25/10/23 | 15:16:47 | 25 Oct 2023 | | Results of Shareholder’s General Meeting |
| 09/10/23 | 10:02:59 | 9 Oct 2023 | | Date of AGM & Closing Date of Director Nominations |
| 29/09/23 | 10:40:14 | 29 Sept 2023 | | Annual Report for the year ended 30 June 2023 |
| 26/09/23 | 07:36:01 | 26 Sept 2023 | | Letter From the Managing Director |
| 26/09/23 | 07:35:01 | 26 Sept 2023 | | Dispatch of General Meeting Documents |
| 12/09/23 | 07:00:06 | 12 Sept 2023 | | Holding(s) in Company |
| 05/09/23 | 12:34:44 | 5 Sept 2023 | | Results of Shareholder’s General Meeting |
| 01/09/23 | 07:30:28 | 1 Sept 2023 | | Change of registry address notification |
| 31/08/23 | 08:44:51 | 31 Aug 2023 | | 30 June 2023 Preliminary Financial Report |
| 30/08/23 | 08:30:01 | 30 Aug 2023 | | Share Purchase Plan Closed |
| 15/08/23 | 07:29:07 | 15 Aug 2023 | | SPP – Extension of Closing Date |
| 14/08/23 | 07:00:05 | 14 Aug 2023 | | Positive Pre-clinical Trial Results on CimetrA® |
| 04/08/23 | 09:10:19 | 4 Aug 2023 | | Dispatch of General Meeting Documents |
| 03/08/23 | 14:23:12 | 3 Aug 2023 | | Australian Prospectus & Share Purchase Plan |
| 02/08/23 | 10:25:01 | 2 Aug 2023 | | Application for Admission to Trading |
| 01/08/23 | 08:56:54 | 1 Aug 2023 | | MGC Pharma Launches Share Purchase Plan |
| 31/07/23 | 07:00:06 | 31 Jul 2023 | | Permission for first import of Psilocybin |
| 28/07/23 | 09:05:04 | 28 Jul 2023 | | Resignation of Joint Company Secretary |
| 28/07/23 | 08:00:01 | 28 Jul 2023 | | June 2023 Quarter Activity Report and Cash Flow |
| 21/07/23 | 10:56:24 | 21 Jul 2023 | | Holding(s) in Company |
| 18/07/23 | 11:41:58 | 18 Jul 2023 | | PDMR Notification |
| 14/07/23 | 07:00:03 | 14 Jul 2023 | | £0.7 million Fundraising |
| 12/07/23 | 07:00:06 | 12 Jul 2023 | | Further re AMC Places another $1M Order of ArtemiC |
| 07/07/23 | 07:00:07 | 7 Jul 2023 | | AMC Places Another US$1M Order of ArtemiC™ |
| 03/07/23 | 07:00:06 | 3 Jul 2023 | | Reclassification of Psychedelic Compounds |
